Biotoxtech Co., Ltd. (KOSDAQ: 086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,320.00
-70.00 (-2.06%)
Dec 20, 2024, 9:00 AM KST

Biotoxtech Company Description

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea.

It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development.

The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity test, immunotoxicity test, safety pharmacology test, aquatic ecotoxicology test, histopathology/clinical pathology, and animal testing method.

Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Biotoxtech Co., Ltd.
Country South Korea
Founded 2000
Industry Medical Laboratories
Employees 198
CEO Jong-Koo Kang

Contact Details

Address:
Ochang Science Industrial Complex
Cheongwon, Chungcheongbuk-do 363-883
South Korea
Phone 82 4 3210 7777
Website biotoxtech.com

Stock Details

Ticker Symbol 086040
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 8071

Key Executives

Name Position
Jong-Koo Kang Chief Executive Officer